305
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Cancer Chemopreventive Effects of the Flavonoid-Rich Fraction Isolated from Papaya Seeds

, , , , , , , , , & show all
Pages 857-871 | Received 10 Dec 2013, Accepted 03 Feb 2014, Published online: 12 May 2014

REFERENCES

  • Ambrosone CB and Tang L: Cruciferous vegetable intake and cancer prevention: role of nutrigenetics. Cancer Prev Res (Phila) 2, 298–300, 2009.
  • Hail N Jr, Cortes M, Drake EN, and Spallholz JE: Cancer chemoprevention: a radical perspective. Free Radic Biol Med 45, 97–110, 2008.
  • Greenwald P and Dunn BK: Do we make optimal use of the potential of cancer prevention? Recent Results Cancer Res 181, 3–17, 2009.
  • Vang O, Ahmad N, Baile CA, Baur JA, Brown K, et al.: What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 6, e19881, 2011.
  • Efferth T: Pharmacognosy and molecular pharmacology of small molecules of natural origin for cancer therapy and chemoprevention. Curr Drug Targets 7, 237–238, 2006.
  • Nobili S, Lippi D, Witort E, Donnini M, Bausi L, et al.: Natural compounds for cancer treatment and prevention. Pharmacol Res 59, 365–378, 2009.
  • Rayalam S, Della-Fera MA, and Baile CA: Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis. Mol Nutr Food Res 55, 177–185, 2011.
  • Lee KW, Bode AM, and Dong Z: Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11, 211–218, 2011.
  • Dietz BM and Bolton JL: Biological reactive intermediates (BRIs) formed from botanical dietary supplements. Chem Biol Interact 192, 72–80, 2011.
  • Scott E, Steward WP, Gescher AJ, and Brown K: Resveratrol in human cancer chemoprevention-choosing the ‘right’ dose. Mol Nutr Food Res 56, 7–13, 2012.
  • Speciale A, Chirafisi J, Saija A, and Cimino F: Nutritional antioxidants and adaptive cell responses: an update. Curr Mol Med 11, 770–789, 2011.
  • Zhou K, Wang H, Mei W, Li X, Luo Y, et al.: Antioxidant activity of papaya seed extracts. Molecules 16, 6179–6192, 2011.
  • Chávez-Quintal P, González-Flores T, Rodríguez-Buenfil I, and Gallegos-Tintoré S: Antifungal activity in ethanolic extracts of Carica papaya L. cv. Maradol leaves and seeds. Indian J Microbiol 51, 54–60, 2011.
  • Mishra PK: A pragmatic & translational approach of human biomonitoring to methyl isocyanate exposure in Bhopal. Indian J Med Res 135, 479–484, 2012.
  • Mishra PK, Raghuram GV, Bhargava A, Ahirwar A, Samarth R, et al.: In vitro and in vivo evaluation of the anticarcinogenic and cancer chemopreventive potential of a flavonoid-rich fraction from a traditional Indian herb Selaginella bryopteris. Br J Nutr 106, 1154–1168, 2011.
  • Pathak N, Mishra PK, Manivannan B, and Lohiya NK: Sterility due to inhibition of sperm motility by oral administration of benzene chromatographic fraction of the chloroform extract of the seeds of Carica papaya in rats. Phytomedicine 7, 325–333, 2000.
  • Lohiya NK, Pathak N, Mishra PK, and Manivannan B: Contraceptive evaluation and toxicological study of aqueous extract of the seeds of Carica papaya in male rabbits. J Ethnopharmacol 70, 17–27, 2000.
  • Lohiya NK, Mishra PK, Pathak N, Manivannan B, Bhande SS, et al.: Efficacy trial on the purified compounds of the seeds of Carica papaya for male contraception in albino rat. Reprod Toxicol 20, 135–148, 2005.
  • Harborne JB: Phytochemical methods—a guide to modern techniques of plant analysis, 3rd ed. New Delhi, India: Springer, 2005.
  • Mishra PK, Panwar H, Bhargava A, Gorantla VR, Jain SK, et al.: Isocyanates induces DNA damage, apoptosis, oxidative stress, and inflammation in cultured human lymphocytes. J Biochem Mol Toxicol 22, 429–440, 2008.
  • Mishra PK, Khan S, Bhargava A, Panwar H, Banerjee S, et al.: Regulation of isocyanate-induced apoptosis, oxidative stress, and inflammation in cultured human neutrophils: isocyanate-induced neutrophils apoptosis. Cell Biol Toxicol 26, 279–291, 2010.
  • Mishra PK, Gorantla VR, Akhtar N, Tamrakar P, Jain SK, et al.: Analysis of cellular response to isocyanate using N-succinimidyl N-methylcarbamate exposure in cultured mammalian cells. Environ Mol Mutagen 50, 328–336, 2009.
  • Jain D, Pathak N, Khan S, Raghuram GV, Bhargava A, et al.: Evaluation of cytotoxicity and anticarcinogenic potential of Mentha leaf extracts. Int J Toxicol 30, 225–236, 2011.
  • Mishra PK, Bhargava A, Raghuram GV, Jatawa SK, Akhtar N, et al.: Induction of genomic instability in cultured human colon epithelial cells following exposure to isocyanates. Cell Biol Int 33, 675–683, 2009.
  • Bhargava A, Raghuram GV, Pathak N, Varshney S, Jatawa SK, et al.: Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radic Biol Med 51, 1806–1814, 2011.
  • Raghuram GV, Pathak N, Jain D, Pandey H, Panwar H, et al.: Molecular characterization of isocyanate-induced male germ-line genomic instability. J Environ Pathol Toxicol Oncol 29, 213–234, 2010.
  • Mishra PK, Raghuram GV, Panwar H, Jain D, Pandey H, et al.: Mitochondrial oxidative stress elicits chromosomal instability after exposure to isocyanates in human kidney epithelial cells. Free Radic Res 43, 718–728, 2009.
  • Bhargava A, Khan S, Panwar H, Pathak N, Punde RP, et al.: Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytes. Virus Res 153, 143–150, 2010.
  • Khan S, Raghuram GV, Bhargava A, Pathak N, Chandra DH, et al.: Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus. Transl Res 158, 344–359, 2011.
  • Bhargava A, Punde RP, Pathak N, Dabadghao S, Desikan P, et al.: Status of inflammatory biomarkers in the population that survived the Bhopal gas tragedy: a study after two decades. Ind Health 48, 204–208, 2010.
  • Mishra PK, Bhargava A, Khan S, Pathak N, Punde RP, et al.: Prevalence of hepatitis C virus genotypes and impact of T helper cytokines in achieving sustained virological response during combination therapy: a study from Central India. Indian J Med Microbiol 28, 358–362, 2010.
  • Raghuram GV, Pathak N, Jain D, Panwar H, Pandey H, et al.: Molecular mechanisms of isocyanate induced oncogenic transformation in ovarian epithelial cells. Reprod Toxicol 30, 377–386, 2010.
  • Panwar H, Raghuram GV, Jain D, Ahirwar AK, Khan S, et al.: Cell cycle deregulation by methyl isocyanate: Implications in liver carcinogenesis. Environ Toxicol 29, 284–297, 2012. doi:10.1002/tox.21757
  • Mishra PK, Bhargava A, Raghuram GV, Gupta S, Tiwari S, et al.: Inflammatory response to isocyanates and onset of genomic instability in cultured human lung fibroblasts. Genet Mol Res 8, 129–143, 2009.
  • Ostermann T, Krummenauer F, Heusser P, and Boehm K: Health economic evaluation in complementary medicine: development within the last decades concerning local origin and quality: Complement Ther Med 19, 289–302, 2011.
  • Harvey AL: Natural products in drug discovery. Drug Discov Today 13, 894–901, 2008.
  • Milaeva ER: Metal-based antioxidants—potential therapeutic candidates for prevention the oxidative stress-related carcinogenesis: mini-review: Curr Top Med Chem 11, 2703–2713, 2011.
  • Neergheen VS, Bahorun T, Taylor EW, Jen LS, and Aruoma OI: Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 278, 229–241, 2010.
  • Vargas AJ, Sittadjody S, Thangasamy T, Mendoza EE, Limesand KH, et al.: Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53. Integr Cancer Ther 10, 328–340, 2011.
  • Maloney DG: Anti-CD20 antibody therapy for B-cell lymphomas. N Engl J Med 366, 2008–2016, 2012.
  • García-Lafuente A, Guillamón E, Villares A, Rostagno MA, and Martínez JA: Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 58, 537–552, 2009.
  • Chen S: Natural products triggering biological targets—a review of the anti-inflammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis. Curr Drug Targets 12, 288–301, 2011.
  • Serafini M, Peluso I, and Raguzzini A: Flavonoids as anti-inflammatory agents. Proc Nutr Soc 69, 273–278, 2010.
  • Owoyele BV, Adebukola OM, Funmilayo AA, and Soladoye AO: Anti-inflammatory activities of ethanolic extract of Carica papaya leaves. Inflammopharmacology 16, 168–173, 2008.
  • Gosselin K, Martien S, Pourtier A, Vercamer C, Ostoich P, et al.: Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells. Cancer Res 69, 7917–7925, 2009.
  • Mladenka P, Zatloukalová L, Filipský T, and Hrdina R: Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med 49, 963–975, 2010.
  • Kook D, Wolf AH, Yu AL, Neubauer AS, Priglinger SG, et al.: The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci 49, 1712–1720, 2008.
  • Segal A, Solomon JJ, and Li FJ: Isolation of methylcarbamoyl-adducts of adenine and cytosine following in vitro reaction of methyl isocyanate with calf thymus DNA. Chem Biol Interact 69, 359–372, 1989.
  • Tamura N, Aoki K, and Lee MS: Selective reactivities of isocyanates towards DNA bases and genotoxicity of methylcarbamoylation of DNA. Mutat Res 283, 97–106, 1992.
  • Panwar H, Jain D, Khan S, Pathak N, Raghuram GV, et al.: Imbalance of mitochondrial-nuclear cross talk in isocyanate mediated pulmonary endothelial cell dysfunction. Redox Biol 1, 163–171, 2013.
  • Beyerbach A, Farmer PB, and Sabbioni G: Biomarkers for isocyanate exposure: synthesis of isocyanate DNA adducts. Chem Res Toxicol 19, 1611–1618, 2006.
  • Duthie SJ: Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process. Mol Nutr Food Res 51, 665–674, 2007.
  • Borgovan T, Bellistri JP, Slack KN, Kopelovich L, Desai M, et al.: Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E. J Exp Ther Oncol 8, 129–144, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.